CancerNCT01248676
An Evaluation of the Usability and Usefulness of a Multi-language Online Patient Education Module
A study testing Multi-language Online Patient Education Module in addition to standard Patient Teaching in people with Cancer, run by Sunnybrook Health Sciences Centre at 1 site in Canada.
Trial summary
The purpose of this study is to determine if multi-language patients will find the multi-language capabilities of the online modules useful for better understanding of the general information regarding radiation therapy. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Cancer
- What is being tested?
- Multi-language Online Patient Education Module in addition to standard Patient Teaching
- How many people
- 10 participants
- Where
- 1 siteCanada
- Study dates
- Dec 2010to Apr 2011
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- first/second language in one of the module languages with the ability to understand and communicate English to an understandable degree, basic computer skills, and the ability to complete 20-30 minutes of testing.
Who cannot join
- inability to participate in 20-30 minutes of usability testing.
Trial locations and contacts
1 site in 1 country.
Canada1 site
Odette Cancer Centre at Sunnybrook Health Sciences
Toronto, Ontario, M4N3M5
About this study
Official title: An Evaluation of the Usability and Usefulness of a Multi-language Online Patient Education Module: A Pilot Study
The purpose of this study is to determine if multi-language patients will find the multi-language capabilities of the online modules useful for better understanding of the general information regarding radiation therapy.
Read the detailed description
Research shows that treatment-related information is the most important informational need of cancer patients and online media sources are gaining popularity as a cancer communication method. It is important to know whether having multi-language online education modules are usable for and beneficial to the multicultural cancer patient population at Sunnybrook Hospital, given that recent research suggests that this cancer population in general faces many barriers to effective online cancer communication. Approximately 10 new patients from the radiation oncology clinic at Sunnybrook Hospital will be screened to participate in the study. Usability testing will involve a combination of interviewing, observation, think-aloud methodology and a short survey.Results will be analyzed by assessing the percentage of patients identifying with a certain level of the Likert scale on the survey as well as through content analysis of responses to the interview and open-ended survey questions.
- Conditions
- Cancer
- Being tested
- Multi-language Online Patient Education Module in addition to standard Patient Teaching
- Keywords
- cancer radiation patient education
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Multi-language Online Patient Education Module in addition to standard Patient TeachingOther
Patients are usually be given a 5-10 minute "new patient teaching" before their radiation therapy simulation and planning appointment and before their first radiation therapy treatment appointment. Patients will be asked to view an online patient education module before their radiation therapy simulation and planning appointment or before their first radiation therapy treatment appointment. Then patients will be asked to participate in an interview session and fill out a survey (attached). They will still receive "new patient teaching" from the therapists before their radiation therapy simulation and planning or radiation therapy treatment appointment.
What is being measured
The primary outcome is the main question the study is designed to answer.
Patients will be asked to give their rating (Likert scale) on the usefulness of the information on the patient education site with regard to their upcoming radiation simulation and treatment.
Measured: Within one month of patients initial consultation with the Radiation Oncologist
Secondary outcomes (1)
Patients will be asked to give their rating (Likert scale) on how easily the online patient education module is to navigate.
Measured: Within one month of patients initial consultation with the Radiation Oncologist
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Nov 2010 (estimated)
- Study startDec 2010
- Primary completionApr 2011
- Study completionApr 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by Sunnybrook Health Sciences CentreThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sunnybrook Health Sciences Centre
- Sponsor type
- University, hospital or other
- Investigators
- Lisa S Di Prospero, MSc, Principal investigator, Odette Cancer Centre at Sunnybrook Health Sciences Centre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01248676
- Sponsor's protocol ID
- Cindy Multi-Language Online
- Status last verified
- Aug 2011
- First submitted
- 18 Nov 2010
- Last updated
- 16 Aug 2011
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Aug 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Evaluation of the Usability and Usefulness of a Multi-language Online Patient Education Module: A Pilot Study
- ClinicalTrials.gov ID
- NCT01248676
- Acronym / sponsor ID
- Cindy Multi-Language Online
- Conditions
- Cancer
- Keywords
- cancer radiation patient education
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- Sunnybrook Health Sciences CentreUniversity, hospital or other
- Study start
- Dec 2010
- Primary completion
- Apr 2011 (actual)
- Study completion
- Apr 2011 (actual)
- First posted
- 25 Nov 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine if multi-language patients will find the multi-language capabilities of the online modules useful for better understanding of the general information regarding radiation therapy.
Detailed description
Research shows that treatment-related information is the most important informational need of cancer patients and online media sources are gaining popularity as a cancer communication method. It is important to know whether having multi-language online education modules are usable for and beneficial to the multicultural cancer patient population at Sunnybrook Hospital, given that recent research suggests that this cancer population in general faces many barriers to effective online cancer communication. Approximately 10 new patients from the radiation oncology clinic at Sunnybrook Hospital will be screened to participate in the study. Usability testing will involve a combination of interviewing, observation, think-aloud methodology and a short survey.Results will be analyzed by assessing the percentage of patients identifying with a certain level of the Likert scale on the survey as well as through content analysis of responses to the interview and open-ended survey questions.
Study design
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- first/second language in one of the module languages with the ability to understand and communicate English to an understandable degree, basic computer skills, and the ability to complete 20-30 minutes of testing.
Key exclusion criteria (1 listed)
- inability to participate in 20-30 minutes of usability testing.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Multi-language Online Patient Education Module in addition to standard Patient TeachingPatients are usually be given a 5-10 minute "new patient teaching" before their radiation therapy simulation and planning appointment and before their first radiation therapy treatment appointment. Patients will be asked to view an online patient education module before their radiation therapy simulation and planning appointment or before their first radiation therapy treatment appointment. Then patients will be asked to participate in an interview session and fill out a survey (attached). They will still receive "new patient teaching" from the therapists before their radiation therapy simulation and planning or radiation therapy treatment appointment. | Other | – |
Primary outcome
Patients will be asked to give their rating (Likert scale) on the usefulness of the information on the patient education site with regard to their upcoming radiation simulation and treatment.
Time frame: Within one month of patients initial consultation with the Radiation Oncologist
1 secondary outcome
Patients will be asked to give their rating (Likert scale) on how easily the online patient education module is to navigate.
Time frame: Within one month of patients initial consultation with the Radiation Oncologist
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Aug 2011.
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lisa S Di Prospero, MSc principal investigator
Odette Cancer Centre at Sunnybrook Health Sciences Centre
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Multi-language Online Patient Education Module in addition to standard Patient Teaching in people with Cancer, run by Sunnybrook Health Sciences Centre at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Aug 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patients will be asked to give their rating (Likert scale) on the usefulness of the information on the patient education site with regard to their upcoming radiation simulation and treatment. (time frame: Within one month of patients initial consultation with the Radiation Oncologist). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2011; AzTrials last refreshed its copy on 7 Nov 2026.